Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 1.440
-0.055 (-3.68%)
Jan 21, 2026, 2:52 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 157.75 million as of January 21, 2026. Its market cap has increased by 42.81% in one year.
Market Cap
157.75M
Enterprise Value
146.80M
Revenue
50.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.44
Market Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 157.75M, an increase of 152.42%. That is a compound annual growth rate of 8.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 157.75M | 1.70% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.19B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 39.51B |
| Medicover AB | 30.95B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |